Physician
Milano, Michelangelo
Milano, Michelangelo was paid $4.43M by Medicaid between Jan 2018 and Dec 2024, across 148 billing codes. Its largest line is 87636, Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B — 10% of everything it billed.
33Billing provider infoMILANO, MICHELANGELO
EVANSTON, IL 60201
EVANSTON, IL 60201
33aNPI1922055144assigned 05/31/2006
33bProvider typeAnatomic Pathology Physician
28Total paid$4.43M
24GClaims658,394
24DCodes billed148
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology Physician providers in Illinois
Rank by total paid#2 of 38
Median peer was paid$56K
This provider vs. median78×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 77,242 | $376K | |
| 2019 | 95,590 | $486K | |
| 2020 | 102,322 | $585K | |
| 2021 | 96,018 | $782K | |
| 2022 | 99,262 | $775K | |
| 2023 | 98,544 | $769K | |
| 2024incomplete | 89,416 | $654K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 10% | 6,833 | 5,914 | $445K |
| 80053 | Comprehensive metabolic panel | 8.3% | 72,719 | 50,373 | $368K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.5% | 4,374 | 3,875 | $244K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.4% | 10,138 | 8,609 | $241K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.7% | 9,590 | 9,162 | $207K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.5% | 70,323 | 49,141 | $200K |
| 87632 | 4.5% | 2,281 | 1,990 | $198K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 4.2% | 1,101 | 1,034 | $188K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.8% | 21,078 | 19,007 | $169K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.5% | 2,173 | 1,995 | $111K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.2% | 24,484 | 12,185 | $98K |
| 85027 | 2.0% | 31,573 | 16,627 | $89K |
136 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.9% | 2,450 | $84K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.9% | 3,157 | $83K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.7% | 3,413 | $75K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.7% | 3,389 | $75K |
| 83735 | 1.6% | 21,295 | $69K | |
| 87631 | 1.4% | 1,356 | $64K | |
| 87040 | 1.4% | 7,866 | $61K | |
| 80061 | Lipid panel | 1.3% | 15,542 | $57K |
| 84484 | 1.2% | 13,314 | $54K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.2% | 10,719 | $54K |
| 82805 | 1.1% | 2,980 | $49K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 6,252 | $49K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 6,070 | $44K |
| 82962 | <1% | 38,877 | $43K | |
| 83690 | <1% | 11,935 | $40K | |
| 81001 | <1% | 27,556 | $38K | |
| 81025 | <1% | 16,229 | $35K | |
| 87641 | <1% | 1,520 | $33K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 10,357 | $32K |
| 83880 | <1% | 2,959 | $31K | |
| 83605 | <1% | 6,796 | $30K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 880 | $28K |
| 87186 | <1% | 4,528 | $25K | |
| 87634 | <1% | 962 | $24K | |
| 84100 | <1% | 12,035 | $24K | |
| 86850 | <1% | 7,819 | $23K | |
| 84439 | <1% | 5,035 | $22K | |
| 86901 | <1% | 9,787 | $22K | |
| 85610 | <1% | 11,283 | $21K | |
| 87480 | <1% | 1,649 | $20K | |
| 87510 | <1% | 1,646 | $20K | |
| 87486 | <1% | 968 | $20K | |
| 87581 | <1% | 969 | $20K | |
| 85730 | <1% | 6,532 | $19K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 139 | $19K |
| 86140 | <1% | 7,859 | $18K | |
| 87081 | <1% | 6,118 | $18K | |
| 86900 | <1% | 9,783 | $17K | |
| 82261 | <1% | 2,043 | $16K | |
| 86803 | <1% | 1,997 | $16K | |
| 85379 | <1% | 4,146 | $15K | |
| 82728 | <1% | 3,813 | $15K | |
| 83520 | <1% | 2,393 | $15K | |
| 87506 | <1% | 174 | $15K | |
| 82607 | <1% | 2,531 | $15K | |
| 83498 | <1% | 2,115 | $14K | |
| 87660 | <1% | 1,707 | $14K | |
| 83021 | <1% | 2,123 | $12K | |
| 82017 | <1% | 2,038 | $11K | |
| 86780 | <1% | 1,278 | $11K | |
| 84702 | <1% | 2,243 | $10K | |
| 83550 | <1% | 2,322 | $10K | |
| 87070 | <1% | 3,224 | $9K | |
| 82803 | <1% | 1,378 | $9K | |
| 87088 | <1% | 1,642 | $9K | |
| 82570 | <1% | 3,714 | $9K | |
| 87340 | <1% | 1,324 | $9K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 968 | $8K |
| 84703 | <1% | 2,379 | $8K | |
| 80076 | <1% | 2,220 | $8K | |
| 83540 | <1% | 2,564 | $8K | |
| 81003 | <1% | 7,387 | $8K | |
| 82550 | <1% | 2,821 | $8K | |
| 82128 | <1% | 2,040 | $7K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 170 | $7K |
| 86038 | <1% | 832 | $6K | |
| 82776 | <1% | 2,049 | $6K | |
| 86480 | <1% | 238 | $6K | |
| 82760 | <1% | 2,047 | $6K | |
| 87205 | <1% | 2,850 | $5K | |
| 86920 | <1% | 1,680 | $5K | |
| 86403 | <1% | 1,442 | $5K | |
| 85652 | <1% | 3,494 | $5K | |
| 82746 | <1% | 797 | $5K | |
| 82247 | <1% | 2,071 | $4K | |
| 83655 | <1% | 712 | $4K | |
| 84145 | <1% | 1,497 | $4K | |
| 86706 | <1% | 590 | $4K | |
| 87449 | <1% | 450 | $4K | |
| 84550 | <1% | 1,886 | $4K | |
| 82042 | <1% | 1,265 | $3K | |
| 83516 | <1% | 359 | $3K | |
| 86376 | <1% | 525 | $2K | |
| 84480 | <1% | 480 | $2K | |
| 86880 | <1% | 697 | $2K | |
| 84156 | <1% | 1,566 | $2K | |
| 82784 | <1% | 216 | $2K | |
| 84403 | <1% | 126 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 55 | $1K |
| 82043 | <1% | 722 | $1K | |
| 86308 | <1% | 531 | $1K | |
| 88307 | <1% | 35 | $1K | |
| 87077 | <1% | 566 | $1K | |
| 85007 | <1% | 639 | $1K | |
| 82140 | <1% | 270 | $984.89 | |
| 83970 | <1% | 62 | $961.92 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 67 | $960.11 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 30 | $750.00 |
| 87493 | <1% | 52 | $733.20 | |
| 86430 | <1% | 235 | $726.67 | |
| 84481 | <1% | 138 | $709.56 | |
| 82947 | <1% | 412 | $689.65 | |
| 86664 | <1% | 73 | $643.10 | |
| 80164 | <1% | 127 | $581.92 | |
| 83615 | <1% | 217 | $555.77 | |
| 84132 | <1% | 295 | $412.37 | |
| 80069 | <1% | 93 | $393.36 | |
| 86665 | <1% | 26 | $364.80 | |
| 82951 | <1% | 56 | $352.46 | |
| 86769 | <1% | 14 | $337.10 | |
| 84300 | <1% | 146 | $309.34 | |
| 85045 | <1% | 243 | $302.90 | |
| 83001 | <1% | 32 | $290.88 | |
| 82565 | <1% | 122 | $263.29 | |
| 83013 | <1% | 13 | $262.73 | |
| 82150 | <1% | 80 | $255.20 | |
| 80074 | <1% | 13 | $250.12 | |
| 80047 | <1% | 40 | $183.69 | |
| 83002 | <1% | 29 | $161.24 | |
| 84311 | <1% | 47 | $144.77 | |
| 86704 | <1% | 18 | $141.30 | |
| 84146 | <1% | 17 | $114.07 | |
| 82533 | <1% | 17 | $114.07 | |
| 82952 | <1% | 56 | $106.86 | |
| 80320 | <1% | 2,932 | $102.80 | |
| 85384 | <1% | 32 | $94.35 | |
| 82436 | <1% | 36 | $83.76 | |
| 84133 | <1% | 36 | $75.48 | |
| 87045 | <1% | 15 | $70.80 | |
| 81002 | <1% | 49 | $57.08 | |
| 86592 | <1% | 29 | $56.00 | |
| 80178 | <1% | 17 | $54.91 | |
| 84295 | <1% | 65 | $49.79 | |
| 85060 | <1% | 13 | $40.50 | |
| 85049 | <1% | 31 | $23.40 | |
| 80329 | 0% | 237 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.